BSE filing, NSE: EMCURE. Summary written from the filing by ALFA Finder's alert engine.
Emcure Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,871.80
- Market cap
- ₹35,510 Cr
- Revenue (annual)
- ₹9,204 Cr
- Net profit (annual)
- ₹924.4 Cr
- P/E (TTM)
- 35.1×Sector 45.9×
- Promoter holding
- 77.82%-0.01% QoQ
- FII holding
- 4.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emcure Pharmaceuticals Ltd
All →Emcure Pharmaceuticals Other Announcement
Emcure Pharmaceuticals submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance disclosure under SEBI.
Emcure Pharmaceuticals Board Meeting Date
Emcure Pharmaceuticals will hold a board meeting on November 03, 2026, to consider and approve the company's standalone and consolidated financial results for the quarter.
Emcure Pharmaceuticals Acquisition
Emcure Pharmaceuticals approved the merger of its wholly-owned subsidiaries, Zuventus Healthcare and Emcutix Biopharmaceuticals, into itself. The internal restructuring involves no cash consideration or share issuance.
Emcure Pharmaceuticals Legal & Regulatory
Emcure Pharmaceuticals received Income-tax Department orders imposing aggregate penalties of Rs. 57.74 Crore for assessment years 2015-16 to 2021-22. The company is evaluating legal remedies.
- Value
- ₹57.74 Cr
Emcure Pharmaceuticals Investor Presentation: Key Takeaways
Emcure reported strong Q1 FY27 momentum with revenue of INR 92,035 Mn and PAT of INR 9,413 Mn for FY26. Strategy focuses on chronic-led domestic expansion and differentiated international portfolios.
Emcure Pharmaceuticals Annual General Meeting
Emcure Pharmaceuticals held its 45th Annual General Meeting on September 21, 2026. The meeting transacted ordinary and special business, including the approval of a final dividend.
Other management change announcements
All →Himadri Speciality Chemical Management Change
Himadri Speciality Chemical's board revised its senior management list following organisational restructuring. Six personnel are listed, including the CFO and Company Secretary.
HMT Management Change
HMT Ltd intimated the resignation of Aparna R, Assistant General Manager (F&A), who ceases as CFO and KMP effective close of business on October 30, 2026. Her resignation letter is attached.
Share India Securities Management Change
Share India Securities appointed Krishan Singh Barguzar as Non-Executive Independent Director for 36 months, effective 30 October 2026. He is a former SBI Chief General Manager.
Indian Renewable Energy Development Agency Management Change
IREDA appointed Jatin Kumar Nayak as CMD effective October 30, 2026. Dr. Bijay Kumar Mohanty ceased to hold the additional CMD charge that day.
Kwality Wall's (India) Management Change
Kwality Wall's appointed Tahir Toloy Tanridagli as MD and CEO for three years from November 1, 2026. Vivek Sarbhai ceases as Senior Management Personnel from October 31.
- Execution
- 3 years (1 November 2026 to 31 October 2029)
Power Grid Corporation of India Management Change
Power Grid named Pankaj Pandey Director (Operations) on a Ministry of Power order, effective on or after 1 December 2026. He retires on 30 June 2030.